Niacinamide: An Emerging Consideration
Mechanistically grounded, supported by emerging human evidence, available without prescription — what to know if you're considering it.
Most supplements that get attention in glaucoma circles fall between unhelpful and unproven. Niacinamide is different — it has a specific, well-understood mechanism of action that connects directly to how retinal ganglion cells (RGCs) survive metabolic stress, and a small but growing body of clinical evidence in human glaucoma patients. It isn't a cure. It isn't a substitute for IOP control or any prescribed treatment. But for many patients, it's worth understanding and worth considering.
This article covers what niacinamide is, why it may help, what the evidence shows, what to actually take, when it matters most, and what to discuss with your physician.
Continue reading with Premium
The rest of this article — and the full library of clinically-oriented depth content on triggers, mechanisms, altitude, diurnal patterns, and correlation — unlocks with a premium subscription.
Foundational articles (understanding your data, how to use ODyn, iCare basics, normal-tension glaucoma literacy) stay free and accessible to everyone.
Start your free trial →